Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samaramedprom is a significant Russian pharmaceutical company established in 1993, dedicated to manufacturing and distributing a wide range of affordable and effective medicines. The company specializes in producing finished dosage forms, pharmaceutical substances, disinfectants, and dietary supplements at its GMP-compliant facilities. Its product portfolio includes iconic generic medications such as Corvalol, Mukaltin, and Cordiamin, which are staples in the healthcare systems of Russia and the CIS. Beyond its own brand, Samaramedprom operates as a contract manufacturing organization (CMO), providing services from formulation development to final packaging for external partners. Headquartered with a presence in Moscow and major production sites in the Samara and Kaluga regions, the company plays a vital role in ensuring the availability of essential pharmaceutical preparations and medical supplies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samaramedprom.